Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-11

Clinical Trial Update: A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 randomized study comparing melphalan + prednisone (MP) versus melphalan + prednisone + thalidomide (MPT) in newly diagnosed elderly patients with mult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Melphalan (Alkeran) (melphalan)
  • Prednisone (Deltasone) (prednisone)
  • Thalidomide (Thalomid) (thalidomide)

Snippet

Sponsor: Gruppo Italiano Studio Linfomi | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED